Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year [Yahoo! Finance]
Is Artivion (AORT) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Artivion, Inc. (NYSE: AORT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.
ENSEMBLE ORTHOPEDICS ANNOUNCES 700TH IMPLANTATION OF ITS MINIMALLY-INVASIVE PYROCARBON INTERPOSITIONAL CMC [Yahoo! Finance]